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Introduction
Uterine leiomyoma is the most common benign tumor
in women of reproductive age. It is characterized by
excessive accumulation of extracellular matrix (ECM)
in the tissue. Although it is not malignant disease, for
one-third of these women, the tissue fibrosis may
cause several reproductive and gynecological prob-
lems, such as menorrhagia, dysmenorrhoea, chronic
pelvic pain, infertility, recurrent miscarriage, preterm
delivery and postpartum haemorrhage [4]. Since there
is no effective pharmacological treatment of the
leiomyomas usually they are subject for hysterectomy.
Growth of these tumors is dependent on ovarian hor-
mones, estrogens and progesterone as evidenced by
their remarkable shrinkage both in menopause and in
the pseudomenopause state created by the use of
GnRH analogue (GnRH-a) treatment. Leiomyomata
rarely develop before puberty, increase in size during
pregnancy, and markedly regress after menopause.
Thus far, it has not been possible to demonstrate in
vitro evidence of direct growth stimulatory action of
steroid hormones on isolated myometrium and leiomy-
oma cells. This finding indicates that intermediary fac-
tors, such as growth factors or cytokines, most likely
play pivotal roles in this process. Most of the available
information on leiomyoma growth suggest a vital role
of estrogen and progesterone in this process [7]. Actu-
ally, Brandon et al. [3] demonstrated increased expres-
sion of estrogen receptor and progesteron receptor in
uterine leiomyomas compared to those in the adjacent
normal myometrium. 
During the past two decades, some progress has
been made towards the understanding of the pathogen-
esis of the disease from the clinical, genetic, epidemi-
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ological and molecular perspectives [7]. However, the
cause of the disease remain largely unknown.
Since ECM constitutes a significant proportion of
leiomyoma mass the tissue is called fibroid. It has been
reported [8] that leiomyomas contains 50% more ECM
than the corresponding myometrium. The ECM of
leiomyomas consists primarily of collagen,
fibronectin, and proteoglycans. Several other studies
reported relative overexpression of collagen by
leiomyomas as compared with corresponding
myometrium [17,19,20]. 
The present study was undertaken to evaluate the
collagen biosynthesis, prolidase activity, expressions
of integrin receptor and MMP in cultured in vitro
human myometrium and leiomyoma cells treated with
estradiol, selective estrogen receptors modulators and
estrogen receptor down regulator, ICI 182.780.
Materials and methods
Cell culture. Human myometrium and leiomyoma tissue were
obtained from six women (mean age 47 years, range 45-53) under-
going hysterectomy either for fibroids or for mennorhagia or
benign ovarian tumors. Leiomyoma and myometrium cells were
obtained from the patients operated in the Department of Gynecol-
ogy and Department of Reproduction and Gynecological
Endocrinology Medical University of Bialystok Poland. Tissues
were etching in colagenase, after 5 hours rubbed by cell scraper.
Cells were maintained in 75 cm2 tissue culture flask (Sarsted,
USA), under standard culture conditions; at 37°C, 5% CO2 humid-
ified incubator in Dulbeco's modified Eagle's medium (Sigma-
Aldrich), were renewal every 2 days. Culture media contained 10%
of adult bovine serum, and enriched with 50 U/ml antibiotic,
antimycotic solution (penicillin, streptomycin, amphotericin B
(Sigma-Aldrich Poland).
When cells reached 80% confluence, they were collected and
seeded in 6 well culture plates (Sarsted, USA) at a density of 0.25
× 106 cells per well. The cells were incubated for 24 h prior to
treatment and allowed to proliferate to 70% - 80% confluence
before commencement of each experiment, without serum in D-
MEM/F12 medium without phenol red. 
The control was media with PBS only, which was the solvent
for E2, ICI, R, T.
Determination of prolidase activity. The activity of prolidase was
determined according to the method of Myara [14] which is based
on measurement of proline by Chinard`s reagent [5]. Briefly, the
monolayer was washed three times with 0.15 M of NaCl. Cells
were harvested by scraping and suspended in 0.15 M NaCl, cen-
trifuged at low speed (200 × g) and the supernatant was discarded.
The cell pellet was suspended in 0.3 ml of 0.05 M Tris-HCl, pH
7.8, and sonicated 3 times for 10 seconds at 0°C. Samples were
then centrifuged (16.000 × g, 30 min.) at 4°C. Supernatant was
used for protein determination and then prolidase activity assay.
Activation of prolidase required incubation with manganese; 100
μl of supernatant incubated with 100 μl of 0.05 M Tris-HCl,
pH=7.8 containing 2 mM MnCl (II) for 2 hours at 37°C. The prol-
idase reaction was initiated by adding 100 μl of the incubated mix-
ture to 100 μl of 94 mM glycyl-proline (Gly-Pro) for a final con-
centration of 47 mM Gly-Pro. After additional incubation for 1
hour at 37°C, the reaction was terminated with 1 ml of 0.45 M
trichloroacetic acid. In parallel tubes reaction was terminated at
time "zero" (without incubation). The released proline was deter-
mined by adding of 0.5 ml of the trichloroacetic acid supernatant
to 2 ml of a 1:1 mixture of glacial acetic acid: Chinard`s reagent
(25 g of ninhydrin dissolved at 70°C in 600 ml of glacial acetic
acid and 400 ml of 6 M orthophosphoric acid) and incubated for 10
min. at 90°C. The amount of proline released was determined col-
orimetrically by absorbance at 515 nm and calculated by using pro-
line standards. Protein concentration measured by the method of
Lowry. Enzyme activity was reported as nanomoles per minute per
milligram of supernatant protein.
Collagen production. Incorporation of radioactive precursor
into extracellular matrix components was measured after label-
ing confluent cells in serum-free medium for 24 h with the 5-
[3H] proline (5 μCi/ml, 28 Ci/mmol). Incorporation of label into
collagen was determined by digesting proteins with purified C.
histolyticum collagenase according to the method of Peterkofsky
et al. (16). 
SDS-PAGE. Slab SDS/PAGE was used, according to the method
of Laemmli [11]. Samples of cell supernatants (25-50 μg of pro-
tein) were incubated for 10 min. at 100°C in 62.5 mmol/l Tris-HCl,
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Fig. 1. Collagen biosynthesis in myometrium and leiomyoma cells
treated for 24 h with various concentrations of estradiol (E), ralox-
ifene (R), tamoxifen (T) and ICI 182.780.
Fig. 2. Prolidase activity in myometrium and leiomyoma cells
treated for 24 h with various concentrations of estradiol (E), ralox-
ifene (R) and tamoxifen (T).
pH=6.8, containing 2.0% (w/v) SDS, 5% (v/v) β-mercaptoethanol,
10% (v/v) glycerol and 0.001% bromophenol blue. Samples were
electrophoresed on a Tris-Glycine gels at 100V per gel for 30 min-
utes at room temperature. 
Western immunoblot analysis. After SDS-PAGE, the gels were
allowed to equilibrate for 5 min in 25 mmol/l Tris, 0.2 mol/l
glycine in 20% (v/v) methanol. The protein was transferred to 0.2
μm pore-sized nitrocellulose at 100 mA for 90 minutes using a
BioRad electrophoresis unit according to the method described in
the manual accompanying the unit. The membrane was blocked
with 5% dried milk in TBS-T for 1 hour in room temperature,
slowly shaking. Then the nitrocellulose was incubated with mono-
clonal antibody against β1-integrin at concentration 1:5,000 or
polyclonal antibodies against prolidase or β-actin at concentration
1:1,000 overnight. After the incubation, nitrocellulose was washed
with TBS-T (1 x 15 min and 2 × 10 min) intensively shaking. In
order to analyze the proteins second alkaline phosphatase labeled
antibodies against mouse`s Fc IgG or against rabbit's IgG were
added at concentration 1:2,500 in TBS-T and incubated for 1 hour
slowly shaking. Then the membrane was extensively washed with
TBS-T (5 × 10 min) and submitted to BCIP/NBT western blotting
detection system. 
Zymography. Gelatinolytic activity was determined according to
the method of Unemori and Werb (23). Cell culture medium was
concentrated 10 times using 3 kDa cut off centricons, mixed with
Laemmli sample buffer [11], containing 2,5% SDS (without reduc-
ing agent). An equal amounts (about 20 μg) of protein was elec-
trophoresed under non-reducing conditions on 10% polyacry-
lamide gels impregnated with 1 mg/ml gelatin. After electrophore-
sis, the gels were incubated in 2% Triton X-100 for 30 min at 37°C
to remove SDS and incubated for 18-24 h at 37°C in substrate
buffer (50 mM Tris-HCl buffer, pH=8.0, containing 5 mM CaCl2).
After staining with Coomassie briliant blue R250, gelatin-degrad-
ing enzymes present in tissue extract were identified as clear zones
in a blue background.
Statistical analysis. In all experiments, the mean values for six
independent experiments ± standard deviation were calculated.
The results were submitted to statistical analysis using Student's t-
test, accepting p<0.05 as significant.
Results
It is well known that estrogens participate in collagen
metabolism [1,18]. We used estradiol, SERMs (tamox-
ifen and raloxifene) and ICI 182.780 to test their effect
on collagen biosynthesis in cultured in vitro human
myometrium and leiomyoma cells. Collagen biosynthe-
sis in the cells was measured by 5[3H] - proline incor-
poration into proteins susceptible to the action of bacte-
rial collagenase. As can be seen from Fig. 1, leiomyoma
cells produce higher amount of collagen compared to
myometrium cells. Estradiol at 5 nM concentration is a
potent stimulator of collagen biosynthesis in leiomyoma
cells while it has no effect on protein synthesis in
myometrium cells. Increase in estradiol concentration to
10 nM contributed to decrease in collagen biosynthesis
to 40% of control value in myometrium cells and almost
completely inhibited the process in leiomyoma cells.
The addition of raloxifene into the culture medium con-
tributed to decrease in collagen biosynthesis in leiomy-
oma cells while it had no significant effect in myometri-
um cells. On the other hand tamoxifen slightly induced
collagen biosynthesis in myometrium cells and slightly
inhibited in leiomyoma cells.
We considered whether increase in collagen
biosynthesis is a result of increase of prolidase activi-
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Fig. 3. Western immunoblot analysys of
β1-integrin receptor in myometrium (A)
and leiomyoma (B) cells treated for 24
h with various concentrations estradiol
(E), raloxifene (R), tamoxifen (T) and
ICI 182.780.
Fig. 4. MMP-2 activity in cell culture
medium of myometrium (A) and
leiomyoma (B) treated for 24 h with
various concentrations estradiol (E),
raloxifene (R), tamoxifen (T) and ICI
182.780.
ty. Intracellular prolidase activity was measured in the
cells incubated for 24 hours with estradiol, raloksifen
or tamoxifen as well as with estrogen receptor down
regulator, ICI 182.780. The results are shown in Fig. 2.
Leiomyoma cells showed about four fold increase in
prolidase activity in comparison to normal myometri-
um cells. Estradiol and raloxifen however inhibited
collagen biosynthesis in leiomyoma in dose dependent
manner, but stimulated collagen biosynthesis in nor-
mal myometrium cells. In respect to tamoxifen it was
found to slightly decrease of collagen biosynthesis in
leiomyoma cells and slightly induce this process in
myometrium cells. As described previously, prolidase
activity and collagen biosynthesis are stimulated
through the β1-integrin subunit, presumably a compo-
nent of the α2 β1 integrin receptor (15). Our results
show that β1-integrin receptor expression is increased
in leiomyoma cells comparing to normal cells (Fig. 3).
We observed no effect of estradiol, tamoxifen, ralox-
ifene and ICI on the receptor expression in normal and
leiomyoma cells. Since disturbances in collagen
metabolism are usually accompanied by deregulation
of collagen degradation we determined the gelatinolyt-
ic activity in the studied cells. As can be seen from Fig-
ure 4, normal myometrium and leiomyoma cells con-
tain gelatinase of 72 kDa (MMP2) however, its activi-
ty is much higher in leiomyoma than in control cells. It
is interesting that estradiol slightly increased the activ-
ity of the collagenase in myometrium cells while in
leiomyoma cells it inhibited the enzyme activity. Both,
tamoxifen and raloxifen inhibited the activity of
MMP2, compared to control.
Discussion
Since the tumors of uterus do not exist in animals
model, cultures of human myometrium and leiomy-
oma cells are the only model for studying the regula-
tion of cell proliferation and biosynthesis of extracel-
lular matrix in the tissue. We examined the influence
of the estrogen receptor activation on the metabolism
of collagen in leiomyoma and myometrium cultured
cells. It is known that collagen interaction with cell
surface integrin receptor induces signaling that it is
involved in regulation of cell proliferation and survival
and also may play a pivotal role in the development
and tumor growth.
The biosynthesis of extracellular matrix is depend-
ent on estrogen receptor activation [13,21]. The basic
massage of our study is that estradiol much stronger
inducer of collagen biosynthesis in leiomyoma cells
than in myometrium cells. In opposite raloxifene was
found to be much stronger inhibitor of the protein syn-
thesis in tumor cells than in control cells. It suggests
that estrogen receptor activation may represent mech-
anism for up-regulation of collagen synthesis in
leiomyoma cells. It is supported by studies of Leppert
et al. [12] showing that leiomyomas contain an abnor-
mal collagen fibril structure and orientation, which
suggests that the well-regulated fibril formation in
myometrium is altered in leiomyomas. Alterations in
collagen genes expression and collagenolytic activity
may play a role in the pathogenesis of leiomyomas as
well as some post-transcriptional regulations. One
such a regulatory mechanism was found at the level of
prolidase.
Prolidase plays an important role in collagen
biosynthesis at post-transcriptional level, because pro-
vides proline for collagen biosynthesis and may be a
rate-limiting factor in the regulation of the protein pro-
duction. The leiomyoma cells evokes higher prolidase
activity in comparison to myometrium cells. The
mechanism of the up-regulation of prolidase activity is
not known. It can not be due to estradiol since it
induces inhibition of prolidase activity in leiomyoma
cells while it stimulates in myometrium cells. Addi-
tionally, the effect of raloxifene or tamoxifen on proli-
dase activity has no or little correlation with collagen
biosynthesis. 
The activity of prolidase is known to be regulated
by interaction of collagen with β1-integrin receptor. In
our study we observed increased β1-integrin receptor
expression in leiomyoma cells in comparison to nor-
mal cells. 
Activation of signaling through β1-integrin cascade
represents important mechanism for stimulation of
collagen production in collagen synthesizing cells
[22]. Upregulation of the signaling cascade may con-
tribute to stimulation of collagen synthesis which is the
dominant process during the development of leiomy-
oma [9,10].
In our study we found increased MMP2 activity in
leiomyoma cells comparing to myometrium cells. It is
interesting that estradiol increased the activity of the
gelatinase in myometrium cells while it inhibited the
enzyme activity in leiomyoma cells. Both, tamoxifen
and raloxifene were found to decrease the activity of
MMP2, compared to control. Ubiquitination and
degradation of estrogen receptor by ICI 182.780 does
not lead to any changes in MMP activity.
MMP plays an important role in the balance
between collagen biosynthesis and degradation and its
activity reflects the rate of collagen turn-over [2].
Tumor remodelling plays a major role in both growth
and regression of uterine tumors and it is regulated by
matrix metalloproteinases (MMPs) and tissue
inhibitors of MMPs (TIMPs) [6]. We observed up-reg-
ulation of MMP-2 in leiomyoma cells in comparison to
myometrium cells.
Wolanska et al. [24] examined the activities of
matrix metalloproteinases (MMPs) in human
myometrium and uterine leiomyomas in various stages
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of growth. It was found that both myometrium and the
investigated tumors contain collagenolytic enzymes:
MMP-1, MMP-2, MMP-3 and MMP-9. It seems that
during leiomyoma remodeling the most important is
MMP-2. In control myometrium only 10% of MMP-2
exists in an active form, whereas in tumors, especially
in large ones, the values reach 30%. It is suggested that
the high activity of MMP-2 is responsible for remod-
eling of extracellular matrix in the growing tumors.
Since raloxifene strongly inhibited the collagen
biosynthesis, our results confirm the clinical observa-
tions of shrinkage of leiomyomata in women treated
with raloxifene.
In conclusion, the data are consistent with a mech-
anism for up-regulation of extracellular matrix colla-
gen, which is characterized by increase in collagen
synthesis and decrease in collagen breakdown. The
results suggest that altered regulation of extracellular
matrix in leiomyoma may be due to integrin - depend-
ent signaling and estrogen activity. We postulate that
the both factors are likely candidates to promote colla-
gen biosynthesis and enlarge the tumor volume of
leiomyoma.
References 
[ 1] Baldekas JC, Smith B, Gerstenfeld L, Sonenshein GE,
Franzblau K. Effects of 17  estradiol on the biosynthesis of
collagen in cultured bovine aortic smooth muscle cells. Bio-
chemistry. 1981;20:2162-2163.
[ 2] Bodner-Adler B, Bodner K, Kimberger O, Czerwenka K,
Leodolter S, Mayerhofer K. Expression of matrix metallopro-
teinases in patients with uterine smooth muscle tumors: an
immunohistochemical analysis of MMP-1 and MMP-2 pro-
tein expression in leiomyoma, uterine smooth muscle tumor
of uncertain malignant potential, and leiomyosarcoma. J Soc
Gynecol Investig. 2004;11(3):182-6.
[ 3] Brandon DD, Erickson TE, Keenan EJ, Strawn EY, Novy MJ,
Burry KA, Warner C, Clinton GM. Estrogen receptor gene
expression in human uterine leiomyomata. J Clin Endocrinol
Metab. 1995;80:1876-81.
[ 4] Buttram VC Jr, Reiter RC. Uterine leiomyomata: etiology,
symptomatology, and management. Fertil Steril. 1981;36:
433-45.
[ 5] Chinard FP. Photometric estimation of proline and ornithine.
J Biol Chem. 1952;199:91-95. 
[ 6] Dou Q, Tarnuzzer RW, Williams RS, Schultz GS, Chegini
N.Differential expression of matrix metalloproteinases and
their tissue inhibitors in leiomyomata: a mechanism for
gonadotrophin releasing hormone agonist-induced tumour
regression. Mol Hum Reprod. 1997;3(11):1005-14.
[ 7] Flake GP, Andersen J, Dixon D.Etiology and pathogenesis of
uterine leiomyomas: a review. Environ Health Perspect.
2003;111(8):1037-54. 
[ 8] Fujita M. Histological and biochemical studies on collagen in
human uterine leiomyomas. Hokkaido Igaku Zasshi. 1985;60:
602-15.
[ 9] Hynes RO. Integrins: versitility, modulation and signaling in
cell adhesion. Cell. 1992;69:11-25. 
[10] Juliano RL. The role of B1 integrins in tumor. Cancer Biolo-
gy. 1993;4:277-283. 
[11] Laemmli UK. Cleavage of structural proteins during the
assembly of the head of baceriophage T4. Nature (London).
1970;227:680-685. 
[12] Leppert PC, Baginski T, Prupas C, Catherino WH, Pletcher S,
Segars JH. Comparative ultrastructure of collagen fibrils in
uterine leiomyomas and normal myometrium. Fertil Steril.
2004;82(supp l):1182-7.
[13] Miltyk W, Anchim T, Wolczynski S, Palka J. Estrogen-
dependent regulation of prolidase activity in breast cancer
MCF-7 cells. Gynecol Endocrinol. 1999;13(3):166-74.
[14] Myara I, Charpentier C, Lemonnier A. Optimal conditions for
prolidase assay by proline colorimetric determination: appli-
cation to imidodipeptiduria. Clin Chim Acta. 1982;125:193-
205. 
[15] Pa³ka JA, Phang J. Prolidase activity in fibroblasts is regulat-
ed by interaction of extracellular matrix with cell surface inte-
grin receptors. Journal of Cellular Biochemistry. 1997;67:
166-175.
[16] Peterkofsky B, Chojkier M & Bateman J. Determination of
collagen synthesis in tissue and cell culture system. In: Eds M
Furthmay. CRC Press, Boca Raton, Fl. Immunochemistry of
the Extracellular Matrix. 1982;19-47. 
[17] Puistola U, Ristili L, Ristili J, Kauppila A. Collagen metabo-
lism in gynecologic patients: changes in the concentration of
the aminoterminal propeptide of type 3 procollagen in serum.
Am J Obstet Gynecol. 1990;163:1276-81.
[18] Schmid MECh, Froesch ER. Enhanced osteoblast prolifera-
tion and collagen gene expression by estradiol. Proc Nat
Acadf Sci USA. 1998;85:2307-2310.
[19] Sozen I, Arici A. Interactions of cytokines, growth factors,
and the extracellular matrix in the cellular biology of uterine
leiomyomata. Fertil Steril. 2002;78(1):1-12. 
[20] Stewart EA, Friedman AJ, Peck K, Nowak RA. Relative over-
expression of collagen type 1 and collagen type 3 messenger
ribonucleic acids by uterine leiomyomas during the prolifera-
tive phase of the menstrual cycle. J Clin Endocrinol Metab.
1994;79:900-6.
[21] Surazynski A, Jarzabek K, Haczynski J, Laudanski P, Palka J,
Wolczynski S. Differential effects of estradiol and raloxifene
on collagen biosynthesis in cultured human skin fibroblasts.
Int J Mol Med. 2003;12(5):803-9.
[22] Taylor CV, Letarte M, Lye SJ. The expression of integrins and
cadherins in normal human uterus and uterine leiomyomas.
Am J Obstet Gynecol. 1996;175(2):411-9.
[23] Unemori EN, Werb Z. Reorganization of polymerized actin: a
possible trigger for induction of procollagenase in fibroblasts
cultured in and on collagen gels. J Cell Biol. 1986;103:1021-
1031.
[24] Wolañska M, Sobolewski K, Bañkowski E, Jaworski S.
Matrix metalloproteinases of human leiomyoma in various
stages of tumor growth. Gynecol Obstet Invest. 2004;58(1):
14-8.
185Collagen biosynthesis in leyomyoma 
